Seimon, R V
Espinoza, D
Finer, N http://orcid.org/0000-0003-2468-6804
James, W P T
Legler, U F
Coutinho, W
Sharma, A M
Van Gaal, L
Maggioni, A P
Sweeting, A
Torp-Pedersen, C http://orcid.org/0000-0003-2892-6131
Gebski, V
Caterson, I D
Article History
Received: 29 August 2014
Revised: 25 November 2014
Accepted: 5 December 2014
First Online: 18 December 2014
Competing interests
: NF: member of SCOUT Executive Steering Committee (ESC) received payments from Abbott, as advisor for Novo Nordisk, Merck, sanofi-aventis, GlaxoSmithKline and Shionogi, consultant for Ajinomoto, and provided expert testimony for sanofi-aventis, Vivus, Arena and received a grant from GlaxoSmithKline. WPTJ: Chair of the SCOUT ESC received payment from Abbott; the International Association for the Study of Obesity when he was the President also received a grant from Novo Nordisk. UFL: was an employee of Abbott with equity interest in the Company. WC: member of the SCOUT ESC received payments from Abbott Laboratories, lecture fees and/or travel reimbursement from Abbott, Ache Laboratorios Farmaceuticos S/A, Roche and Novo Nordisk, as advisor for Abbott, Ache Laboratorios Farmaceuticos S/A, GSK, Novo Nordisk, Takeda and Roche, and provided expert testimony for Abbott. AMS: member of the SCOUT ESC received payment from Abbott Laboratories, and as advisor for Abbott, Merck, Arena, Novo Nordisk, sanofi-aventis, GlaxoSmithKline, Boehringer Ingelheim, and NeuroSearch, as consultant for Vivus and Allegan, provided expert testimony for GlaxoSmithKline, received grants from Abbott and Covidian. LVG: Received a research grant from National Research Funds, Belgium; served on the speaker's bureaus of Sanofi-Aventis and Abbott; served as a consultant to Amylin Pharmaceuticals, Sanofi-Aventis, Eli Lilly, and Abbott; member of SCOUT ESC receiving payment from Abbott. IDC: member of SCOUT ESC received payment from Abbott Laboratories, royalties from Wiley-Blackwell as co-editor of an obesity textbook, and the Boden Institute of Obesity, Nutrition and Exercise received grants from Novo Nordisk, sanofi-aventis, Pfizer (Australia), Weight Watchers, Allergan and the Korean Ministry of Agriculture. The remaining authors declare no conflict of interest.